A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC

Clinical trial NCT04900363 · COMPLETED

Trial details

NCT number: NCT04900363
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2021-05-21
Primary completion: 2024-06-28
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.